1/9
07:41 am
mplt
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 [Yahoo! Finance]
Medium
Report
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 [Yahoo! Finance]
1/9
07:00 am
mplt
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
Medium
Report
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
1/5
07:00 am
mplt
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
Low
Report
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
12/20
01:30 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at
Wall Str
Medium
Report
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at
Wall Str
12/16
07:00 am
mplt
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies
Medium
Report
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies
12/4
07:00 am
mplt
MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress
High
Report
MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress
11/26
06:43 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
Low
Report
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
11/26
06:43 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at Zacks Research to a "hold" rating.
Low
Report
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at Zacks Research to a "hold" rating.
1/9
07:07 am
mplt
Form 8-K MapLight Therapeutics, For: Jan 09
Medium
Report
Form 8-K MapLight Therapeutics, For: Jan 09
12/4
07:07 am
mplt
Form 10-Q MapLight Therapeutics, For: Sep 30
High
Report
Form 10-Q MapLight Therapeutics, For: Sep 30
12/4
07:04 am
mplt
Form 8-K MapLight Therapeutics, For: Dec 04
High
Report
Form 8-K MapLight Therapeutics, For: Dec 04
11/20
07:37 pm
mplt
Form SCHEDULE 13D MapLight Therapeutics, Filed by: Catalyst4, Inc.
Medium
Report
Form SCHEDULE 13D MapLight Therapeutics, Filed by: Catalyst4, Inc.
11/18
09:01 pm
mplt
Form 3/A MapLight Therapeutics, For: Oct 25 Filed by: Pavlov George
Low
Report
Form 3/A MapLight Therapeutics, For: Oct 25 Filed by: Pavlov George
11/4
04:21 pm
mplt
Form SCHEDULE 13D MapLight Therapeutics, Filed by: Novo Holdings A/S
Low
Report
Form SCHEDULE 13D MapLight Therapeutics, Filed by: Novo Holdings A/S
10/30
04:32 pm
mplt
Form 4 MapLight Therapeutics, For: Oct 28 Filed by: Novo Holdings A/S
Medium
Report
Form 4 MapLight Therapeutics, For: Oct 28 Filed by: Novo Holdings A/S
10/29
04:17 pm
mplt
Form 4 MapLight Therapeutics, For: Oct 28 Filed by: Catalyst4, Inc.
Medium
Report
Form 4 MapLight Therapeutics, For: Oct 28 Filed by: Catalyst4, Inc.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register